Apple on Monday announced it would pause sales of the Series 9 and Ultra 2 smartwatches in the U.S. starting this week while it deals with a patent dispute involving the smartwatches’ blood oxygen sensor.
Apple’s decision comes after the U.S. International Trade Commission (ITC) ruled in October that it could block the company from importing Apple Watches after it found the devices violate patent rights belonging to Masimo, a medical technology company.
The decision is under review by President Joe Biden’s administration until Dec. 25, but Apple said it is preemptively taking steps toward compliance if the ruling ultimately stands.
Apple said it would pause sales of the Series 9 and Ultra 2 smartwatches on its website starting on Dec. 21, while the company’s retail locations would stop selling those watches after Dec. 24. Versions of the Apple Watch that don’t contain the blood oxygen sensor are unaffected by the patent dispute.
APPLE WATCH FACES POTENTIAL IMPORT BAN OVER…
Read the rest: Source link
Check out our business apps and business podcasts sections, you will be inspired with the type of content we have there.